Literature DB >> 15831363

Association of C825T polymorphism of G protein beta3 subunit with the autonomic nervous system in young healthy Japanese individuals.

Tetsuro Matsunaga1, Kae Nagasumi, Tsubasa Yamamura, Ning Gu, Mariko Nishikino, Yukihiko Ueda, Toshio Moritani, Norihiko Aoki, Kinsuke Tsuda, Koichiro Yasuda.   

Abstract

BACKGROUND: The T allele of the C825T polymorphism of the G protein beta3 subunit gene (GNB3) is reported to be associated with increased intracellular signal transduction and the prevalence of essential hypertension. Because the two major receptors in the autonomic nervous system (ANS), the adrenergic and muscarinic acetylcholine receptors, are G protein-coupled receptors, it was expected that the GNB3 C825T polymorphism was associated with ANS function. In the present study, we have investigated the association of this polymorphism with ANS in young, healthy Japanese male individuals.
METHODS: A total of 94 young, healthy subjects underwent the genotyping for the GNB3 C825T polymorphism and electrocardiogram R-R interval power spectral analysis in supine rest and standing positions.
RESULTS: There were no significant differences among genotypes in any of the characteristics investigated (body mass index, blood pressure, plasma glucose, insulin, lipids, and family history of hypertension, diabetes, or obesity). However, in power spectral analysis of heart rate variability, the very-low-frequency component when standing was higher in TT carriers than in CC carriers, and TT and CT carriers had a significantly higher sympathetic nervous system (SNS) index and lower parasympathetic nervous system (PNS) index when standing than CC carriers. In addition, we found that TT carriers showed no chronological variations in either SNS or PNS index after postural change.
CONCLUSIONS: These observations suggested that GNB3 C825T polymorphism is associated with ANS in youth. These findings raise the possibility that individuals who are T allele carriers are at increased risk for developing hypertension in relation to ANS function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15831363     DOI: 10.1016/j.amjhyper.2004.11.008

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  5 in total

1.  Alpha-adrenoceptor gene variants and autonomic nervous system function in a young healthy Japanese population.

Authors:  Tetsuro Matsunaga; Koichiro Yasuda; Tetsuya Adachi; Ning Gu; Tsubasa Yamamura; Toshio Moritani; Gozoh Tsujimoto; Kinsuke Tsuda
Journal:  J Hum Genet       Date:  2006-10-31       Impact factor: 3.172

2.  β-blocker therapy and heart rate control during exercise testing in the general population: role of a common G-protein β-3 subunit variant.

Authors:  Marcus Dörr; Carsten O Schmidt; Thomas Spielhagen; Alexa Bornhorst; Katharina Hentschel; Christina Franz; Klaus Empen; Thomas Kocher; Scott R Diehl; Heyo K Kroemer; Henry Völzke; Ralf Ewert; Stephan B Felix; Dieter Rosskopf
Journal:  Pharmacogenomics       Date:  2010-09       Impact factor: 2.533

Review 3.  Update on G-protein polymorphisms in hypertension.

Authors:  Haidong Zhu; Xiaoling Wang; Yanhui Lu; Joseph Poola; Zamena Momin; Gregory A Harshfield; Harold Snieder; Yanbin Dong
Journal:  Curr Hypertens Rep       Date:  2006-04       Impact factor: 5.369

4.  Genetic variants in the alpha2C-adrenoceptor and G-protein contribute to ethnic differences in cardiovascular stress responses.

Authors:  Daniel Kurnik; Eitan A Friedman; Mordechai Muszkat; Gbenga G Sofowora; Hong-Guang Xie; William D Dupont; Alastair J J Wood; C Michael Stein
Journal:  Pharmacogenet Genomics       Date:  2008-09       Impact factor: 2.089

5.  The G-protein beta3 subunit 825 TT genotype is associated with epigastric pain syndrome-like dyspepsia.

Authors:  Tadayuki Oshima; Shigemi Nakajima; Tetsuji Yokoyama; Fumihiko Toyoshima; Jun Sakurai; Junji Tanaka; Toshihiko Tomita; Yongmin Kim; Kazutoshi Hori; Takayuki Matsumoto; Hiroto Miwa
Journal:  BMC Med Genet       Date:  2010-01-26       Impact factor: 2.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.